236 related articles for article (PubMed ID: 22826396)
1. Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
Chung WS; Lee KH; Park MS; Lee YJ; Kwon J; Baek SE; Kim MJ
AJR Am J Roentgenol; 2012 Aug; 199(2):349-59. PubMed ID: 22826396
[TBL] [Abstract][Full Text] [Related]
2. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis.
Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
7. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
8. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
[TBL] [Abstract][Full Text] [Related]
10. Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads.
Yeo DM; Choi JI; Lee YJ; Park MY; Chun HJ; Lee HG
J Comput Assist Tomogr; 2014; 38(3):391-7. PubMed ID: 24681857
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
Sacco R; Bargellini I; Bertini M; Bozzi E; Romano A; Petruzzi P; Tumino E; Ginanni B; Federici G; Cioni R; Metrangolo S; Bertoni M; Bresci G; Parisi G; Altomare E; Capria A; Bartolozzi C
J Vasc Interv Radiol; 2011 Nov; 22(11):1545-52. PubMed ID: 21849247
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
14. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Facciorusso A; Mariani L; Sposito C; Spreafico C; Bongini M; Morosi C; Cascella T; Marchianò A; Camerini T; Bhoori S; Brunero F; Barone M; Mazzaferro V
J Gastroenterol Hepatol; 2016 Mar; 31(3):645-53. PubMed ID: 26331807
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
17. MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.
Lee S; Kim KA; Park MS; Choi SY
J Korean Med Sci; 2015 Jul; 30(7):965-73. PubMed ID: 26130962
[TBL] [Abstract][Full Text] [Related]
18. [Economic impact of transarterial chemoembolization with drug eluting beads in the treatment of hepatocellular carcinoma].
Malbranche C; Boulin M; Guiu B; Pernot C; Cercueil JP; Serge Aho L; Musat A; Bedenne L; Hillon P; Guignard MH; Fagnoni P
Bull Cancer; 2011 Jun; 98(6):671-8. PubMed ID: 21642049
[TBL] [Abstract][Full Text] [Related]
19. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
20. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
